USPTO 2015–2025 USPTO PatentsView US Corporation

Multiply LABS Inc.

USPTO PatentsView assignee record - 7 granted patents across 14 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).

7
Total patents granted
14
CPC technology areas
20.7
Avg claims per patent
+150%
5-year filing velocity

The verdict

Multiply holds 7 US patents across 14 technology areas, rank #36,430 of 50,000 tracked assignees.

#36,430
of 50,000 US assignees by volume
Top 52%
by Innovation Score (34.5/100)
20.7
avg claims per patent
+150%
filing velocity, last 5 yrs

Portfolio overview

Multiply LABS Inc. has been granted 7 US utility patents between 2017 and 2025, placing Multiply LABS Inc. at rank #36,430 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.7 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a US Corporation, Multiply LABS Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Multiply sits between Mtek-smart Corporation (7 patents, rank #36,426) and MUST Holding Llc (7 patents, rank #36,434) - the closest US assignees by grant volume. The composite Innovation Score of 34.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 2 in the 2015–2019 window, a +150% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Multiply LABS Inc.'s 20.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Multiply LABS Inc. against peers pursuing similar technology classes.

Who files at Multiply's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Multiply holds 7 patents at rank #36,430, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Multiply

By rank, the assignees closest to #36,430 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Multiply's primary technology class.

Multiply's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

35 Top 52% higher than 48% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201720192020202120242025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Multiply LABS Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 14.3%
2019 1 14.3%
2020 1 14.3%
2021 2 28.6%
2024 1 14.3%
2025 1 14.3%

Which technologies does Multiply LABS Inc. patent most?

Top 14 of 14 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#36,430

Across all tracked assignees

Innovation Score

34.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Multiply LABS Inc. hold?
Multiply LABS Inc. holds 7 US granted patents filed between 2017 and 2025, spanning 14 technology areas.
What is Multiply LABS Inc.'s Innovation Score?
Multiply LABS Inc. has an Innovation Score of 34.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Multiply LABS Inc. focus on?
Multiply LABS Inc.'s top technology area is C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS) with 3 patents. The company has filed patents in 14 CPC subclasses total.
Is Multiply LABS Inc.'s patent filing rate increasing or decreasing?
Multiply LABS Inc.'s recent filing velocity is +150% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Multiply LABS Inc.'s patents?
Multiply LABS Inc.'s patents average 20.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Multiply LABS Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Multiply's 7 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Multiply ranks #36,430 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12M - see who else leads that technology area. C12M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.